تسجيل الدخول/ اشتراك

The GLP-1 obesity market will grow to approximately $90 billion by 2029, driven by significant expansion in obesity treatments, UBS said.

١٩/٠٨ ٢٢:٤٧
صاعد
سبحة

الأخبار الشائعة